CN1956992A - 蒽环类抗生素衍生物 - Google Patents
蒽环类抗生素衍生物 Download PDFInfo
- Publication number
- CN1956992A CN1956992A CNA2005800124959A CN200580012495A CN1956992A CN 1956992 A CN1956992 A CN 1956992A CN A2005800124959 A CNA2005800124959 A CN A2005800124959A CN 200580012495 A CN200580012495 A CN 200580012495A CN 1956992 A CN1956992 A CN 1956992A
- Authority
- CN
- China
- Prior art keywords
- dna
- delivery system
- drug delivery
- cell
- tumour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Abstract
Description
药物 | Ki(Ki×106M-1) | n(碱基对) |
柔红霉素多柔比星化合物1化合物2 | 0.7(0.05)3.2a(0.64)3.3a(0.11)3.0a(0.65) | 3.6(0.17)3.9(0.23)3.4(0.21)3.7(0.31) |
Claims (17)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401066A SE0401066D0 (sv) | 2004-04-22 | 2004-04-22 | Chemical Derivatives |
SE04010666 | 2004-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1956992A true CN1956992A (zh) | 2007-05-02 |
Family
ID=32322666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800124959A Pending CN1956992A (zh) | 2004-04-22 | 2005-04-22 | 蒽环类抗生素衍生物 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20070258890A1 (zh) |
EP (1) | EP1740599B1 (zh) |
JP (1) | JP5156372B2 (zh) |
CN (1) | CN1956992A (zh) |
AT (1) | ATE499378T1 (zh) |
BR (1) | BRPI0510062A (zh) |
DE (1) | DE602005026510D1 (zh) |
ES (1) | ES2360708T3 (zh) |
SE (1) | SE0401066D0 (zh) |
WO (1) | WO2005103065A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102086219A (zh) * | 2010-11-24 | 2011-06-08 | 河南师范大学 | 具有抗癌活性的蒽环类抗生素简单结构类似物及制备方法 |
CN102146107A (zh) * | 2011-01-14 | 2011-08-10 | 河南师范大学 | (s)-2-羟烷基-1,4-二羟基-9,10-蒽醌与糖基缀合物的合成及抗肿瘤活性 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013523726A (ja) * | 2010-04-01 | 2013-06-17 | オンコレナ エービー | 腎細胞癌の改良された治療 |
CN113750047A (zh) * | 2020-05-28 | 2021-12-07 | 浙江大学 | 多功能纳米脂质体、制备方法及应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS539756A (en) * | 1976-07-14 | 1978-01-28 | Microbial Chem Res Found | Antitumers |
GB2007645B (en) * | 1977-10-17 | 1982-05-12 | Stanford Res Inst Int | Benzyl anthracyclines and pharmaceutical compositions containing them |
US4250303A (en) * | 1977-10-17 | 1981-02-10 | Sri International | N-Benzyl anthracyclines |
US4177264A (en) * | 1977-10-17 | 1979-12-04 | Sri International | N-benzyl anthracyclines |
CA1248944A (en) * | 1982-09-28 | 1989-01-17 | Gareth J. Thomas | Anthracycline glycosides |
US4610977A (en) * | 1985-04-08 | 1986-09-09 | The University Of Tennessee Research Corporation | N-alkyl and N-benzyl adriamycin derivatives |
DE3641833A1 (de) * | 1986-12-08 | 1988-06-09 | Behringwerke Ag | Zytostatisch wirksame anthracyclinderivate |
EP0308977B1 (en) * | 1987-09-25 | 1993-12-08 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus |
WO1997034612A1 (en) * | 1996-03-22 | 1997-09-25 | Waldemar Priebe | Bis-anthracyclines with high activity against doxorubicin resistant tumors |
ATE546457T1 (de) * | 1999-03-19 | 2012-03-15 | Waldemar Priebe | Verfahren und zusammensetzungen zur herstellung von c-3' und c-4' -anthracyclin antibiotika |
AU2002358298A1 (en) * | 2001-12-27 | 2003-07-24 | Albany Molecular Research, Inc. | Methods for preparing doxorubicin derivatives |
-
2004
- 2004-04-22 SE SE0401066A patent/SE0401066D0/xx unknown
-
2005
- 2005-04-22 AT AT05733719T patent/ATE499378T1/de not_active IP Right Cessation
- 2005-04-22 WO PCT/SE2005/000596 patent/WO2005103065A1/en active Application Filing
- 2005-04-22 EP EP05733719A patent/EP1740599B1/en not_active Not-in-force
- 2005-04-22 BR BRPI0510062-3A patent/BRPI0510062A/pt not_active IP Right Cessation
- 2005-04-22 US US11/578,159 patent/US20070258890A1/en not_active Abandoned
- 2005-04-22 CN CNA2005800124959A patent/CN1956992A/zh active Pending
- 2005-04-22 DE DE602005026510T patent/DE602005026510D1/de active Active
- 2005-04-22 ES ES05733719T patent/ES2360708T3/es active Active
- 2005-04-22 JP JP2007509425A patent/JP5156372B2/ja not_active Expired - Fee Related
-
2009
- 2009-10-13 US US12/578,380 patent/US8609135B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102086219A (zh) * | 2010-11-24 | 2011-06-08 | 河南师范大学 | 具有抗癌活性的蒽环类抗生素简单结构类似物及制备方法 |
CN102146107A (zh) * | 2011-01-14 | 2011-08-10 | 河南师范大学 | (s)-2-羟烷基-1,4-二羟基-9,10-蒽醌与糖基缀合物的合成及抗肿瘤活性 |
CN102146107B (zh) * | 2011-01-14 | 2014-12-31 | 河南师范大学 | (s)-2-羟烷基-1,4-二羟基-9,10-蒽醌与糖基缀合物的合成及抗肿瘤活性 |
Also Published As
Publication number | Publication date |
---|---|
US20070258890A1 (en) | 2007-11-08 |
US8609135B2 (en) | 2013-12-17 |
BRPI0510062A (pt) | 2007-10-16 |
JP2007533736A (ja) | 2007-11-22 |
EP1740599B1 (en) | 2011-02-23 |
US20100092388A1 (en) | 2010-04-15 |
EP1740599A1 (en) | 2007-01-10 |
ATE499378T1 (de) | 2011-03-15 |
DE602005026510D1 (en) | 2011-04-07 |
ES2360708T3 (es) | 2011-06-08 |
WO2005103065A1 (en) | 2005-11-03 |
JP5156372B2 (ja) | 2013-03-06 |
SE0401066D0 (sv) | 2004-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Charrois et al. | Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity | |
RU2497499C2 (ru) | Новые термочувствительные липосомы, содержащие терапевтические агенты | |
CN101711246B (zh) | 治疗细胞增殖性疾病的方法和系统 | |
JP5981214B2 (ja) | リンパ腫の治療のための組成物および方法 | |
JP5615483B2 (ja) | 併用治療用の細胞毒性製剤 | |
Guo et al. | Receptor-specific delivery of liposomes via folate-PEG-chol | |
JP5642892B2 (ja) | 多形膠芽腫の治療のためのマシテンタンを含有する組み合わせ剤 | |
JP2023538503A (ja) | 腫瘍の放射線療法と化学療法を併用する塞栓治療とイメージングに利用可能な多機能マイクロスフェア製剤およびその調製方法 | |
CN1956992A (zh) | 蒽环类抗生素衍生物 | |
Soundararajan et al. | Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response | |
US20070042046A1 (en) | Methods for the treatment of cancer | |
CN1342096A (zh) | 组胺诱导的协同破坏肿瘤作用 | |
Fondell et al. | Nuclisome: a novel concept for radionuclide therapy using targeting liposomes | |
CN101455641B (zh) | 对射线敏感的抗癌药物脂质体制剂 | |
Fondell et al. | In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an 125I-labelled DNA-intercalator | |
Yu et al. | Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer | |
CN1205999C (zh) | 脂质体组合物及放射增敏剂的给药方法 | |
Lee et al. | Therapeutic efficacy evaluation of 111In-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts | |
EP4157457A1 (en) | Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof | |
Wang et al. | Advances of hafnium based nanomaterials for cancer theranostics | |
KR101002672B1 (ko) | 크로몰린 함유 페길화된 리포좀 및 그 제조방법 | |
TWI388339B (zh) | 製造雙功能與雙效奈米靶向性免疫微脂體之套組及微脂體之製造方法 | |
Dando et al. | Liposomal doxorubicin: a review of its use in metastatic breast cancer and potential in non-Hodgkin lymphoma | |
JP2009114167A (ja) | 電離放射線分解性リポソーム、それを用いたリポソーム製剤、並びにリポソームの調整方法 | |
Wang et al. | Advanced Materials for the Delivery of Anti‐Cancer Compounds and Imaging Contrast Agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SJOEBERG STEFAN JORGEN CARLSSON LARS YEDA Owner name: NIUKELI SAM CO., LTD. Free format text: FORMER OWNER: KATARINA EDWARDS Effective date: 20101027 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20101027 Address after: uppsala Applicant after: Niukelisamu Co. Ltd. Address before: uppsala Applicant before: Edwards Katarina Co-applicant before: Sjoeberg Stefan Co-applicant before: Stahl Stefan Co-applicant before: Gedda Lars |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20070502 |